Nail Changes After Ozempic or Mounjaro? What GLP-1 Users Should Know
Share
Nail Changes After Ozempic or Mounjaro? What GLP-1 Users Should Know
Hi, this is ORAEO LAB :)
Have you noticed your fingernails or toenails lifting, changing colour, or becoming more fragile after starting medications such as Ozempic or Mounjaro?
As GLP-1 medications become more widely used for diabetes and weight management, questions about changes in hair, skin, and nails are also becoming more common.
It is understandable to wonder:
“Should I stop taking the medication?”
But current evidence does not show that GLP-1 medications directly damage the nails. Instead, researchers are investigating several possible pathways, including reduced food intake, rapid weight loss, nutritional deficiencies, and potentially other drug-related mechanisms. Importantly, the latest study found an association — not proof of cause and effect. Epocrates
Today, we’ll look at what the research actually shows and three practical ways to manage nail changes without stopping medication on your own.
1. How Common Are Nail Changes?
At the 2026 European Academy of Dermatology and Venereology (EADV) Congress, researchers presented the first controlled study examining nail health among people using GLP-1 receptor agonists.
The study compared 575 GLP-1 users with 1,329 people with obesity and/or type 2 diabetes who had never used these medications.
The difference was notable:
- Nail detachment: 39% of GLP-1 users vs. 9% of controls
- Nail discolouration: 46% vs. 17%
- At least one nail disorder: 66% vs. 53%
So nail detachment was reported more than four times as often among GLP-1 users. Epocrates
However, there is an important limitation.
This was a cross-sectional, self-reported study presented at a medical conference, and it has not established that GLP-1 medications themselves caused the nail problems.
Around half of the users also reported that they had experienced nail problems before starting treatment. Epocrates
So if you have noticed similar changes, you are certainly not alone — but we still need more research to understand exactly why they occur.
2. Could Nutrition Be Part of the Reason?
One important possibility is reduced nutrient intake during GLP-1 treatment.
Medications such as semaglutide and tirzepatide can significantly reduce appetite and may cause early fullness, nausea, or other gastrointestinal symptoms.
As total food intake decreases, it can become harder to consume enough protein, vitamins, and minerals.
A major nutrition advisory on GLP-1 therapy notes that calorie intake may fall substantially during treatment, increasing the risk of inadequate intake of nutrients such as iron and zinc, along with several vitamins and minerals. PubMed Central (PMC)
A large observational study of more than 460,000 adults prescribed GLP-1 receptor agonists also found that nearly 13% had a documented nutritional deficiency or related complication within six months, rising to more than 22% within one year. PubMed Central (PMC)
Protein, iron, zinc, and other nutrients are important for tissues that grow continuously, including hair and nails.
Rapid weight loss itself may also place physiological stress on the body.
This is why nutrition is one of the factors doctors may consider when nail or hair changes appear during treatment.
3. But Nutrition May Not Explain Everything
There is another important point we should be clear about.
In the EADV study, the higher rate of nail problems did not disappear when researchers looked only at participants who had lost weight.
And after adjusting for factors including dermatological conditions and nutritional deficiencies, nail detachment and discolouration were still reported approximately two to three times more often among GLP-1 users. Epocrates
That means it would be too simple to say:
“GLP-1 medications cause nutritional deficiencies, and nutritional deficiencies cause all the nail problems.”
The evidence is not strong enough for that conclusion.
Instead, the current picture looks more like this:
- Reduced food intake and nutritional deficiencies may contribute
- Rapid weight loss may also play a role
- Pre-existing nail conditions need to be considered
- A direct or indirect medication-related effect cannot yet be ruled out
- More prospective research is needed to establish causality
Researchers themselves recommend that patients report nail changes to their healthcare providers rather than stopping an effective treatment on their own. Epocrates
4. Three Things You Can Do Now
If you notice nail changes while taking a GLP-1 medication, the goal is not to panic or immediately stop treatment.
Instead, start by checking the factors that can actually be addressed.
① Make Protein a Priority
Because appetite often decreases with GLP-1 treatment, it can become difficult to eat enough protein without consciously planning for it.
Try including a protein source in each meal, such as:
- Eggs
- Tofu
- Fish
- Chicken
- Greek yoghurt
- Beans or other legumes
Your individual protein needs depend on your age, body composition, kidney function, activity level, and medical condition, so a doctor or dietitian can help determine an appropriate target.
② Ask Whether Nutritional Testing Is Needed
If your food intake has dropped significantly or you are losing weight rapidly, it may be worth discussing your nutritional status with your healthcare provider.
Depending on your symptoms and medical history, they may consider evaluating factors such as:
iron status, ferritin, vitamin levels, or other nutrients.
Do not start high-dose iron, zinc, biotin, or other supplements simply because your nails have changed.
Supplements are not automatically beneficial and may be unnecessary or inappropriate depending on your individual condition.
③ Show Nail Changes to Your Doctor
If you notice:
- Nail lifting or separation
- New discolouration
- Horizontal grooves
- Increased brittleness
- Rapid changes affecting several nails
take clear photographs and show them at your next appointment.
Your healthcare provider may recommend evaluation by a dermatologist, particularly because nail changes can have many causes besides GLP-1 treatment, including infection, trauma, thyroid disease, skin conditions, or nutritional deficiencies.
⚠️ Check Point
Contact a healthcare professional sooner if:
- Nail separation is rapidly worsening or affects several nails
- There is pain, swelling, redness, or discharge around the nail
- Nail changes occur together with significant hair loss
- You are experiencing severe nausea, vomiting, or difficulty eating
- Weight loss is unusually rapid
- You feel extremely fatigued or weak
These signs may warrant evaluation for infection, nutritional problems, or another underlying cause.
🌿 Don’t Stop Your Medication on Your Own
GLP-1 medications have well-established clinical uses in diabetes and obesity management.
Finding a change in your nails does not automatically mean the medication is harming your body or that treatment must be stopped.
The 2026 EADV findings are important because they suggest nail changes may deserve more attention in GLP-1 users.
But they do not yet prove exactly what causes those changes.
The most practical approach is to look at the whole picture:
your rate of weight loss, food intake, nutritional status, existing nail conditions, and medication history.
If something changes, let your healthcare provider know.
Rather than stopping treatment on your own, use the change as a reason to check whether your body is getting the nutrition and medical monitoring it needs.
ORAEO LAB will continue to share practical, evidence-based information on diabetes, weight management, and chronic health conditions.
References
- Nail Detachment Over Four Times More Common Among GLP-1 Users, First Controlled Study Finds — European Academy of Dermatology and Venereology Congress 2026. The study reported nail detachment in 39% of GLP-1 users versus 9% of controls and discolouration in 46% versus 17%. EurekAlert!
- GLP-1 Users Report More Nail Detachment, Hair Loss Than Nonusers — Medical Economics, October 1, 2026. 의료 경제학
- Nutritional Deficiencies and Muscle Loss in Adults With Type 2 Diabetes Using GLP-1 Receptor Agonists — observational study of GLP-1 users. PubMed Central (PMC)
- Nutritional Priorities to Support GLP-1 Therapy for Obesity — joint expert advisory addressing reduced intake and nutritional risks during GLP-1 treatment. PubMed Central (PMC)
Disclaimer: This article is intended for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Do not stop or change a prescribed GLP-1 medication without consulting your healthcare provider. If you notice persistent nail, hair, or other physical changes, discuss them with your doctor or dermatologist. Nutritional supplements should also be used only when appropriate for your individual medical and nutritional needs.